DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Purchased by Xponance Inc.

Xponance Inc. raised its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 7.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 33,034 shares of the medical instruments supplier’s stock after acquiring an additional 2,235 shares during the quarter. Xponance Inc.’s holdings in DENTSPLY SIRONA were worth $627,000 as of its most recent filing with the SEC.

Several other institutional investors also recently made changes to their positions in the stock. Counterpoint Mutual Funds LLC purchased a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at about $299,000. Signaturefd LLC grew its position in DENTSPLY SIRONA by 513.3% during the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier’s stock worth $84,000 after buying an additional 3,706 shares during the period. Royce & Associates LP purchased a new position in DENTSPLY SIRONA in the fourth quarter valued at about $220,000. Envestnet Portfolio Solutions Inc. lifted its position in shares of DENTSPLY SIRONA by 82.9% during the 4th quarter. Envestnet Portfolio Solutions Inc. now owns 15,901 shares of the medical instruments supplier’s stock valued at $302,000 after acquiring an additional 7,206 shares during the period. Finally, Brandes Investment Partners LP boosted its stake in shares of DENTSPLY SIRONA by 67.3% during the 4th quarter. Brandes Investment Partners LP now owns 86,478 shares of the medical instruments supplier’s stock worth $1,641,000 after acquiring an additional 34,776 shares in the last quarter. 95.70% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

XRAY has been the subject of several research analyst reports. Barrington Research dropped their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. Jefferies Financial Group lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating and lowered their target price for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. UBS Group cut their price target on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Finally, Wells Fargo & Company dropped their target price on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. Twelve research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $23.33.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction that occurred on Monday, March 3rd. The stock was purchased at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the acquisition, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.52% of the stock is owned by company insiders.

DENTSPLY SIRONA Stock Down 1.5 %

XRAY stock opened at $15.57 on Wednesday. DENTSPLY SIRONA Inc. has a one year low of $14.78 and a one year high of $33.42. The stock has a market capitalization of $3.10 billion, a P/E ratio of -7.52, a PEG ratio of 1.80 and a beta of 0.98. The company has a 50 day moving average price of $17.86 and a two-hundred day moving average price of $20.40. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.11%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.07%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.